x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

Pharmaceutical Executive

Pharmaceutical Executive Podcast

The Pharm Exec Podcast goes beyond the pages of the Pharmaceutical Executive print magazine and PharmExec.com to bring the latest commercial insights to the C-suite through in-depth interviews. Podcast episodes examine current trends, key conferences, and critical topics in the industry.

science life sciences

All Episodes

18:39

Empty Shelves, Urgent Solutions

Pharmaceutical Executive ·

2024/08/05

Michael Abrams, Managing Partner at Numerof & Associates discusses pharmacy deserts and the main factors that are contributing to the closures of both large and independent pharmacies, what alternative solutions can help ensure continued access to medications for all Americans (particularly those in underserved communities), some potential long term consequences if these pharmacy closures continue, and so much more

en-us

17:10

The Weight-Loss Gold Rush: Legal and Regulatory...

Pharmaceutical Executive ·

2024/07/11

Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses:Top legal and regulatory concerns for investors considering when financing companies developing or marketing GLP-1 drugs How the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs What needs to be done for GLP-1s to be covered Steps companies developing weight-loss medications should take to ensure responsible and ethical practice Advice for investors

en-us

13:10

Healthcare Marketing Strategies for Reaching Diverse...

Pharmaceutical Executive ·

2024/05/14

Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.Link to Honeycomb Health video: https://www.pharmexec.com/view/going-beyond-visuals-to-connect-with-diverse-audiences

en-us

22:37

A Decade in the Anti-Obesity Arena

Pharmaceutical Executive ·

2024/04/30

Currax Pharmaceuticals CEO, George Hampton discusses what patient success has looked like for their oral anti-obesity medication, how expanded access can help with the world's obesity epidemic, when prices should come down, and much more.

en-us

16:18

Fierce Females in the Life Science Space

Pharmaceutical Executive ·

2024/03/28

In this week’s episode, in recognition of international women’s month, Editor Miranda Schmalfuhs has compiled audio clips from interviews with female KOLs that she's been fortunate enough to speak with over this past month for content across a few of our brands. Featured in this episode are: Emma Banks, CEO, ramarketing Jill Jaroch, Senior Director, Women’s Health & Urology Marketing, Astellas Marie Teil, Global Head, UCB’s Women of Childbearing Age Program Julia Lakeland, Chief Product

en-us

20:32

Gen-Z Influence on Pharma M&A

Pharmaceutical Executive ·

2024/03/14

Ian Baer, Founder and Chief Soothsayer, Sooth, discusses their recent data and research about some massive behavioral shifts occurring across Gen-Z, and how pharmaceutical companies and healthcare advertising agencies can adapt their strategies to attract the ever elusive generation.

en-us

22:51

Recent Licensing Agreement Poised to Advance Company ADC

Pharmaceutical Executive ·

2024/01/26

Jingsong Wang, Chairman of Nona Biosciences, discusses Nona Biosciences’ recent exclusive license agreement with Pfizer Inc. for the development and commercialization of HBM9033, an innovative antibody-drug conjugate (ADC) targeting MSLN, a key antigen in various solid tumors. Wang believes that the partnership will significantly advance Nona's Harbour Mice® platform and ADC ecosystem.

en-us

33:10

Cell and Gene Therapy Check-in 2024

Pharmaceutical Executive ·

2024/01/18

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.

en-us

17:00

Reshaping Pharmacovigilance in the age of AI

Pharmaceutical Executive ·

2024/01/04

Sameer Lal, Sr. Vice President, Enterprise Medical Solutions at Indegene, discusses findings from their new study about Reshaping Pharmacovigilance in the age of AI, digital/generative AI opportunities, how quickly the industry is adopting this technology, and much more.

en-us

15:25

Patient Centric Diabetes Care

Pharmaceutical Executive ·

2023/12/14

Dr. Julien Boisdron, Global Head of OneMedical / Chief Medical Officer Roche Diabetes Care, discusses the current standard for diabetes care, the importance of patient advocacy and mental health, what the future of this space holds, and much more.

en-us

00:28:42

DCT Opportunities in Clinical Research

Pharmaceutical Executive ·

2023/10/26

Edward Triebell, Commercial Executive Director for MRN Technologies, discusses the biggest digital trends in clinical research right now, how COVID-19 impacted the use of digital within sponsors and CROs, what the future of DCT services looks like, and much more.

en-us

00:10:31

New FDA SaMD Guidance Will Bring Monumental Changes...

Pharmaceutical Executive ·

2023/10/12

David Klein, co founder and CEO of Click Therapeutics, discusses the new FDA SaMD guidance, the clear differences between companion apps and SaMD, and gives insight into what to expect from this combination in the future.

en-us

00:37:47

Venture Creation Firm Reveals Strategies For...

Pharmaceutical Executive ·

2023/09/28

In this exclusive Pharm Exec Podcast episode with Paul Biondi, executive partner at Flagship Pioneering (the venture creation firm behind Moderna and many other life science firms) and president of Pioneering Medicines, Meg Rivers, managing editor, asks Biondi about 1) the process of founding a company; 2) what factors they consider when deciding whether to partner with a pharmaceutical company (like your partnership with Novo Nordisk) or a foundation (like your partnership with the Cystic Fibrosis

en-us

00:31:18

Avoiding Commercialization Pitfalls for CGTs

Pharmaceutical Executive ·

2023/09/14

Commercialization is a tough road to navigate even for the most established bio/pharmaceutical therapies. But as cell and gene therapies (CGTs) continue to form roots and make a splash worldwide—but specifically in the US—commercialization forms its own version of standardization and best practices.In this exclusive interview with Pharmaceutical Executive, Lung-I Cheng, vice president of CGT, Cencora (formerly AmerisourceBergen), discusses: 1) defining CGT commercialization strategies and

en-us

00:25:22

Ethical AI Practices

Pharmaceutical Executive ·

2023/08/31

Gerald Kierce, co founder and CEO of Trustible and Andrew Gamino-Cheong, the company's CTO and co founder, delve into the realm of artificial intelligence discussing Trustible's mission and its pioneering efforts to ensure ethical AI use particularly in the pharmaceutical industry, and how it navigates complex AI regulations across the globe.

en-us

00:39:08

Drug Pricing Challenges and Navigating The IRA

Pharmaceutical Executive ·

2023/08/17

How to price a bio/pharmaceutical drug is one of the most complex topics for pharmaceutical executives, as there are many factors to consider. Alice Valder Curran, life sciences regulatory expert and partner, Hogan Lovells LLP, reveals the following to Pharmaceutical Executive® in this exclusive Pharm Exec Podcast interview: 1) the biggest drug pricing challenges today; 2) current efforts to lower drug pricing; 3) what companies should consider as it relates to drug pricing from a legal perspective;

en-us

00:39:27

Pharma Marketing in the Age of AI: A New Era Begins

Pharmaceutical Executive ·

2023/08/03

In this podcast, Sharlene Jenner, vice president of engagement strategy at Abelson Taylor and professor of AI and personalization for digital marketers at Southern Methodist University, leads a panel of five industry leaders in a roundtable discussion. The conversation delves into the practicalities of current AI applications and confronts the ethical and regulatory issues related to the technology. The panelists also explore the direct consequences and prospective implications of AI, providing

en-us

00:31:36

Transforming Cancer Care: Data, AI, and...

Pharmaceutical Executive ·

2023/07/20

In this podcast, Mohit Manrao, the SVP and head of US oncology at AstraZeneca, shares his journey from growing up in Northern India with aspirations of becoming a doctor, to leading oncology initiatives at AstraZeneca in the US. A central strategy to ultimately eliminate cancer includes ensuring that the latest scientific advancements are accessible to patients in every zip code and the necessity of integrating the patient perspective at every stage—from early discovery to commercialization,

en-us

00:30:12

AI Frontiers: Navigating the Risks, Rewards, and...

Pharmaceutical Executive ·

2023/07/06

Welcome to a riveting episode of the Pharm Exec podcast, where we dive headfirst into the transformative world of AI in healthcare with Sharlene Jenner, vice president of engagement strategy with the award-winning agency Abelson Taylor. This enlightening conversation traverses the advancements and potential risks of AI, the revolution it is stirring in pharmaceutical marketing, and its game-changing role in understanding complex protein structures. Amid the rapid innovation, we explore the urgent

en-us

00:34:05

Listening is the Key to Good Leadership

Pharmaceutical Executive ·

2023/06/22

We all know that the pharma industry is about people—bettering the lives of others through good research, life-changing pharmaceuticals, and keeping the patient front and center. But Jag Dosanjh, president, US neuroscience and eye care, AbbVie, lives that principle. In this podcast episode, Meg Rivers, managing editor, talks with Dosanjh about what he calls a “people business” and his approach to leadership. He starts his career in the medical sales space before working in many different roles and

en-us

229 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter